Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content

Thrombosis Research

Volumn 102, Issue 4, 2001, Pages 319-330

  Anfossi, Giovanni ^a   Russo, Isabella ^a   Massucco, Paola ^a   Mattiello, Luigi ^a   Balbo, Alessandra ^a   Cavalot, Franco ^a   Trovati, Mariella ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cyclic AMP; Cyclic GMP; Nitric oxide; Platelet aggregation; Sodium nitroprusside; Zaprinast

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; GUANYLATE CYCLASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; ZAPRINAST;

ADULT; ARTICLE; CELL LEVEL; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; KINETICS; MALE; NORMAL HUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ADULT; BLOOD PLATELETS; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MALE; NITROPRUSSIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TIME FACTORS;

EID: 0035873964     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00240-7     Document Type: Article

References (51)

1. Ignarro LJ, Kadowitz PJ Pharmacological and physiological role of cyclic GMP in vascular smooth muscle cell relaxation. Annu Rev Pharmacol. 25:1985;171-191.
2. Murad F Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 78:1986;1-5.
3. Feelisch M, Noack E Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 139:1987;19-30.
4. Loscalzo J Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol. 70:1992;18B-22B. Suppl.
5. Ring T, Knudsen F, Kristensen SD, Larsen CE Nitroglycerin prolongs the bleeding time in healthy males. Thromb Res. 29:1983;181-187.
6. Karlberg K-E, Torfgard K, Ahlner J, Sylven C Dose-dependent effect of nitroglycerin on platelet aggregation and correlation with plasma glyceryl dinitrate concentration in healthy men. Am J Cardiol. 69:1991;802-805.
7. Diodati J, Theroux P, Latour JG, Lacoste L, Lam JYT, Waters D Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction. Am J Cardiol. 66:1990;683-688.
8. Chirkov YY, Naujalis JI, Sage RE, Horowitz JD Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. J Cardiovasc Pharmacol. 21:1993;384-389.
9. Diodati JG, Cannon RO, Hussain N, Quyyumi AA Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris. Am J Cardiol. 75:1995;443-448.
10. Butterworth RJ, Cluckie A, Jackson SH, Buxton-Thomas M, Bath PM Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis. 8:1998;158-165.
11. Schafer AI, Alexander RW, Handin RI Inhibition of platelet function by organic nitrate vasodilators. Blood. 55:1980;649-654.
12. Loscalzo J N-Acetyl-cysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest. 76:1985;703-708.
13. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence of the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 218:1981;739-749.
14. Lau DTW, Chan EK, Benet LZ Glutathione S-transferase-mediated metabolism of glyceryl trinitrate in subcellular fractions of bovine coronary arteries. Pharm Res. 9:1992;1460-1464.
15. Abrams J Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol. 77:1996;31C-37C.
16. Feelisch M The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 17(Suppl. 3):1991;S25-S33.
17. Saxon A, Kattlove HE Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor. Blood. 47:1976;957-961.
18. Bohme E, Graf H, Schulz G Effects of sodium nitroprusside and other smooth muscle cell relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucleotide Res. 9:1978;131-143.
19. 2+ and on aggregation of human platelets. Eur J Pharmacol. 244:1993;37-47.
20. Gerzer R, Karrenbrock B, Siess W, Heim J-M Direct comparison of the effects of nitroprusside, SIN-1, and various nitrates on platelet aggregation and soluble guanylyl cyclase activity. Thromb Res. 52:1988;11-21.
21. Radomski M, Palmer R, Moncada S Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 92:1987;181-187.
22. Harris SN, Rinder CS, Rinder HM, Tracey JB, Smith BR, Hines R Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. Anesthesiology. 83:1995;1145-1152.
23. Conti M, Jin S-LC, Monaco L, Repaske DR, Swinnen JV Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocr Rev. 12:1991;218-234.
24. Haslam RJ, Dickinson NT, Jang EK Cyclic nucleotides and phosphodiesterases in platelets. Thromb Res. 82:1999;412-423.
25. Ghigo D, Alessio P, Foco A, Bussolino F, Costamagna C, Heller R, Garbarino G, Pascarmona GP, Bosia A Nitric oxide synthesis is impaired in glutathione-depleted human umbilical endothelial cells. Am J Physiol. 264:1993;C728-C732.
26. Trovati M, Anfossi G, Massucco P, Mattiello L, Costamagna C, Piretto V, Mularoni E, Cavalot F, Bosia A, Ghigo D Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increase platelet concentrations of both guanosine-3′,5′-cyclic monophosphate and adenosine-3′-5′-cyclic monophosphate. Diabetes. 46:1997;742-749.
27. Born GVR Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
28. Weiss HJ, Rogers J Thrombocytopenia due to abnormalities in platelet release reaction. Blood. 39:1972;2-9.
29. Cardinal DC, Flower RJ The electronic aggregometer: a novel device for assessing platelet behaviour. J Pharmacol Methods. 3:1980;135-158.
30. Johnstone MT, Lam JYT, Lacoste L, Baribeau J, Theroux P, Waters D Methylene blue inhibits the antithrombotic effect of nitroglycerin. J Am Coll Cardiol. 21:1993;255-259.
31. Pasqui AL, Capecchi PL, Ceccatelli L, Mazza S, Gistri A, Laghi Pasini F, Di Perri T Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin. Thromb Res. 61:1991;113-122.
32. Hines R, Barash P Sodium nitroprusside induced platelet disfunction. Anesthesiology. 70:1989;611-615.
33. Azula FJ, Alzola ES, Conde M, Trueba M, Macarulla JM, Marino A Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside. Mol Pharmacol. 50:1996;367-379.
34. Anfossi G, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Cavalot F, Trovati M Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. Diabetes Care. 21:1998;121-126.
35. Trovati M, Anfossi G, Cavalot F, Vitali S, Massucco P, Mularoni E, Schinco P, Tamponi G, Emanuelli G Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes. 35:1986;818-825.
36. Larsson PT, Hjemdahl P, Olsson G, Egberg N, Honstra G Altered platelet function during mental stress and adrenaline infusions in humans: evidence for an increased aggregability in vivo as measured by filtraggregometry. Clin Sci. 76:1989;369-376.
37. Anfossi G, Trovati M Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur J Clin Invest. 26:1996;353-370.
38. Bozzo J, Hernandez MR, Galan AM, Heres M, Ordinas A, Escolar G Antiplatelet effects of sodium nitroprusside in flowing human blood: studies under normoxic and hypoxic conditions. Thromb Res. 97:2000;217-225.
39. Brune B, Hanstein K Rapid reversibility of nitric oxide induced platelet inhibition. Thromb Res. 90:1998;83-91.
40. Gordge MP, Hothersall JS, Noronha-Dutra AA Evidence for a cyclic GMP-independent mechanism in the antiplatelet action of S-nitrosoglutathione. Br J Pharmacol. 124:1998;141-148.
41. Chirkov YY, Chirkova LP, Horowitz JD Nitroglycerin tolerance at the platelet level in patients with angina pectoris. Am J Cardiol. 80:1997;128-131.
42. Macdonald PS, Read MA, Dusting GJ Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb Res. 49:1988;437-449.
43. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M Organic nitrates and compounds that increase intraplatelet guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. Prostaglandins, Leukotrienes Essent Fatty Acids. 49:1993;439-445.
44. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. Gen Pharmacol. 25:1994;1093-1100.
45. Cavallini L, Coassin MG, Borean A, Alexandre A Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-triphosphate receptor and promote its phosphorylation. J Biol Chem. 8:1996;5545-5551.
46. Maurice DH, Haslam RJ Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol. 37:1990;671-681.
47. Daniel JL Inositol phosphate metabolism and platelet activation. Platelets. 1:1990;117-126.
48. Trovati M, Anfossi G Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells. Diabetologia. 41:1998;609-622.
49. Hoffmann G, Gobel BO, Harbrecht U, Vette H, Dusing R Platelet cAMP and cGMP in essential hypertension. Am J Hypertens. 5:1992;847-850.
50. Anfossi G, Russo I, Massucco P, Mattiello L, Perna P, Tassone F, Trovati M L-Arginine modulates aggregation and intracellular cyclic 3′,5′-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent. Thromb Res. 94:1999;307-316.
51. Mollace V, Salvemini D, Vane J Studies on the importance of the proposed release of nitric oxide from platelets. Thromb Res. 64:1991;533-544.